Thromboembolic Event: Clinical Trials

6 trials for Thromboembolic Event, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 not yet recruiting, 1 active not recruiting. 2 Not applicable, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Active not recruiting 1, Completed 1
Phase 42Completed 1, Not yet recruiting 1

Follow Thromboembolic Event: new trials by email Literature Review of Thromboembolic Event trials Research Report on Thromboembolic Event

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety And Field Evaluation of Plasma Lyophilized for Acute and Surgical Management Applications
Freeze-Dried Plasma, Conventional Plasma - Thromboembolic Event, FDP
Phase 4Not yet recruitingTeleflex8672027-10-012026-09-30
Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study
Percutaneous Left Atrial Appendage Occlusion (LAAO), Device-related Thrombus (DRT)
Not yet recruitingInstitut universitaire de cardiologie et de pneumologie de Québec, University Laval1002026-12-012026-03-24
Diffrence in Thromboprofilaksis in Elderly Ostoepenic Hip Fractures According to Mobility Status by Genetic Analysis
Gene Expression Analysis - Hip Fracture of Intertrochanteric Type, Thromboembolic Event
Not applicableActive not recruitingSaglik Bilimleri Universitesi902024-11-012025-06-05
Elaboration of a Prioritization Score for Pharmaceutical Interviews in Patients Treated With Oral Anticoagulants
Survey - Thromboembolic Event
CompletedCHU de Reims1972020-09-202024-05-30
App Reminder on ASA Adherence
Standard Education, Medication Reminder App - Thromboembolic Event
Not applicableCompletedEmory University1952017-10-032019-10-23
Comparison of Thromboembolic Events in Patients Undergoing Thromboprophylactic Treatment With ENOXA® vs Lovenox®
Enoxaparin 4000 IU - Gastrointestinal Neoplasms, Thromboembolic Event
Phase 4CompletedLes Laboratoires des Médicaments Stériles1682015-10-012021-07-29

Narrower conditions

Thromboembolism (6)  ·  Bone Diseases, Metabolic (1)  ·  Embolism and Thrombosis (1)  ·  Gastrointestinal Neoplasms (1)  ·  Hereditary Sensory and Autonomic Neuropathies (1)  ·  Hip Fractures (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Vascular Diseases (6)  ·  Embolism and Thrombosis (5)  ·  Bone Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Femoral Fractures (1)  ·  Fractures, Bone (1)  ·  Gastrointestinal Diseases (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Hip Injuries (1)  ·  Leg Injuries (1)

Interventions

Enoxaparin (1)  ·  Gene Expression Profiling (1)  ·  Surveys and Questionnaires (1)  ·  formycin diphosphate (1)

Sponsors

CHU de Reims (1)  ·  Emory University (1)  ·  Institut universitaire de cardiologie et de pneumologie de Québec, University Laval (1)  ·  Les Laboratoires des Médicaments Stériles (1)  ·  Saglik Bilimleri Universitesi (1)  ·  Teleflex (1)

Countries

Canada (1)  ·  France (1)  ·  Tunisia (1)  ·  Turkey (Türkiye) (1)  ·  United States (1)

Top investigators

Deborah Wittig-Wells, PhD (1)

Results publications

PMID 29103847, PMID 30573129, PMID 31504441, PMID 31634013, PMID 31806131, PMID 34003661, PMID 35440430, PMID 36760206, PMID 37192309, PMID 37910523, PMID 38030357